
|Articles|August 15, 2003
Latanoprost joins Pfizer's prescription card plan
New York-With the recent acquisition of Pharmacia Corp., Pfizer Inc. is making latanoprost ophthalmic solution (Xalatan) and three non-ophthalmic medicines available at a reduced cost to qualified senior citizens.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Physician perspective: Glaucoma eye drops are here to stay
2
SparingVision completes PRODYGY trial patient dosing with SPVN06
3
American College of Physicians Calls for An End of the Term 'Provider' in Policy Paper
4
PRIMA System: A major step in the battle against GA
5




























